These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 33741468)

  • 1. Deciphering the epigenetic network in cancer radioresistance.
    Cabrera-Licona A; Pérez-Añorve IX; Flores-Fortis M; Moral-Hernández OD; González-de la Rosa CH; Suárez-Sánchez R; Chávez-Saldaña M; Aréchaga-Ocampo E
    Radiother Oncol; 2021 Jun; 159():48-59. PubMed ID: 33741468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetics as a determinant of radiation response in cancer.
    Arechaga-Ocampo E
    Int Rev Cell Mol Biol; 2024; 383():145-190. PubMed ID: 38359968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of DNA and RNA Methylation on Radiobiology and Cancer Progression.
    Chi HC; Tsai CY; Tsai MM; Lin KH
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29439529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radio-miRs: a comprehensive view of radioresistance-related microRNAs.
    Pedroza-Torres A; Romero-Córdoba SL; Montaño S; Peralta-Zaragoza O; Vélez-Uriza DE; Arriaga-Canon C; Guajardo-Barreto X; Bautista-Sánchez D; Sosa-León R; Hernández-González O; Díaz-Chávez J; Alvarez-Gómez RM; Herrera LA
    Genetics; 2024 Aug; 227(4):. PubMed ID: 38963803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical Implications.
    Silverman BR; Shi J
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Romance of the three kingdoms in hypoxia: HIFs, epigenetic regulators, and chromatin reprogramming.
    Chen Y; Liu M; Niu Y; Wang Y
    Cancer Lett; 2020 Dec; 495():211-223. PubMed ID: 32931886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioresistance in a human laryngeal squamous cell carcinoma cell line is associated with DNA methylation changes and topoisomerase II α.
    Kim JS; Kim SY; Lee M; Kim SH; Kim SM; Kim EJ
    Cancer Biol Ther; 2015; 16(4):558-66. PubMed ID: 25719218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Advances in Epigenetics for Cancer Radiotherapy.
    Wang Y; Han Y; Jin Y; He Q; Wang Z
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The promise of epigenetic therapy: reprogramming the cancer epigenome.
    Kelly AD; Issa JJ
    Curr Opin Genet Dev; 2017 Feb; 42():68-77. PubMed ID: 28412585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation in human melanoma: past and future.
    Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
    Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy.
    Castilho RM; Squarize CH; Almeida LO
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28704968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinatorial epigenetic regulation of non-coding RNAs has profound effects on oncogenic pathways in breast cancer subtypes.
    Xu J; Wang Z; Li S; Chen J; Zhang J; Jiang C; Zhao Z; Li J; Li Y; Li X
    Brief Bioinform; 2018 Jan; 19(1):52-64. PubMed ID: 27742663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Critical Role of Hypoxic Microenvironment and Epigenetic Deregulation in Esophageal Cancer Radioresistance.
    Macedo-Silva C; Miranda-Gonçalves V; Henrique R; Jerónimo C; Bravo I
    Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31739546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential.
    Xu X; Peng Q; Jiang X; Tan S; Yang Y; Yang W; Han Y; Chen Y; Oyang L; Lin J; Xia L; Peng M; Wu N; Tang Y; Li J; Liao Q; Zhou Y
    Exp Mol Med; 2023 Jul; 55(7):1357-1370. PubMed ID: 37394582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming Agents.
    Oronsky B; Scicinski J; Kim MM; Cabrales P; Salacz ME; Carter CA; Oronsky N; Lybeck H; Lybeck M; Larson C; Reid TR; Oronsky A
    Biomolecules; 2016 Jul; 6(3):. PubMed ID: 27384589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer.
    Fanale D; Castiglia M; Bazan V; Russo A
    Adv Exp Med Biol; 2016; 937():207-28. PubMed ID: 27573902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic modifications in colorectal cancer: molecular insights and therapeutic challenges.
    Vaiopoulos AG; Athanasoula KCh; Papavassiliou AG
    Biochim Biophys Acta; 2014 Jul; 1842(7):971-80. PubMed ID: 24561654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylome analysis identifies epigenetic silencing of FHIT as a determining factor for radiosensitivity in oral cancer: an outcome-predicting and treatment-implicating study.
    Lin HY; Hung SK; Lee MS; Chiou WY; Huang TT; Tseng CE; Shih LY; Lin RI; Lin JM; Lai YH; Chang CB; Hsu FC; Chen LC; Tsai SJ; Su YC; Li SC; Lai HC; Hsu WL; Liu DW; Tai CK; Wu SF; Chan MW
    Oncotarget; 2015 Jan; 6(2):915-34. PubMed ID: 25460508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Chromatin Remodeling for Cancer Therapy.
    Kaur J; Daoud A; Eblen ST
    Curr Mol Pharmacol; 2019; 12(3):215-229. PubMed ID: 30767757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.